Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1219

Jan 13, 2021

J&J’s one-shot Covid vaccine is safe and generates promising immune response in early trial

Posted by in category: biotech/medical

The new clinical trial data shows a single shot of the vaccine “gives sustainable antibodies,” Dr. Paul Stoffels, J&J chief scientific officer, told CNBC.

Jan 13, 2021

Using electricity to increase the amount of data that can be stored

Posted by in categories: bioengineering, biotech/medical, computing, genetics

A team of researchers at Columbia University has developed a way to allow DNA strands to store more data. In their study, published in the journal Science, the group applied a small amount of electricity to DNA strands to allow for encoding more information than was possible with other methods.

For several years, researchers have been looking for ways to increase data storage capacity—storage requirements are expected to exceed capacity in the near future as demand skyrockets. One such approach has involved encoding data into strands of DNA—prior research has shown that it is possible. In the early stages of such research, scientists manually edited strands to add characteristics to represent zeroes or ones. More recently, researchers have used the CRISPR gene editing tool. Most such studies used DNA extracted from the tissue of deceased animals. More recently, researchers have begun efforts to move the research to living animals because it will last longer. And not just in the edited strands—the information they contain could conceivably be passed on to offspring, allowing data to be stored for very long periods of time.

Back in 2017, another team at Columbia University used CRISPR to detect a certain signal—in their case, it was the presence of sugar molecules. Adding such molecules resulted in gene expressions of plasmid DNA. Over time, the editing process was improved as genetic bits were added to represent ones and zeroes. Unfortunately, the system only allowed for storing a few bits of data.

Jan 13, 2021

Engineers observe avalanches in nanoparticles for the first time

Posted by in categories: biotech/medical, chemistry, engineering, finance, nanotechnology, quantum physics

Researchers at Columbia Engineering report today that they have developed the first nanomaterial that demonstrates “photon avalanching,” a process that is unrivaled in its combination of extreme nonlinear optical behavior and efficiency. The realization of photon avalanching in nanoparticle form opens up a host of sought-after applications, from real-time super-resolution optical microscopy, precise temperature and environmental sensing, and infrared light detection, to optical analog-to-digital conversion and quantum sensing.

“Nobody has seen avalanching behavior like this in nanomaterials before,” said James Schuck, associate professor of mechanical engineering, who led the study published today by Nature. “We studied these new nanoparticles at the single-nanoparticle level, allowing us to prove that avalanching behavior can occur in nanomaterials. This exquisite sensitivity could be incredibly transformative. For instance, imagine if we could sense changes in our chemical surroundings, like variations in or the actual presence of molecular species. We might even be able to detect coronavirus and other diseases.”

Avalanching processes—where a cascade of events is triggered by series of small perturbations—are found in a wide range of phenomena beyond snow slides, including the popping of champagne bubbles, nuclear explosions, lasing, neuronal networking, and even financial crises. Avalanching is an extreme example of a nonlinear process, in which a change in input or excitation leads to a disproportionate—often disproportionately large—change in output signal. Large volumes of material are usually required for the efficient generation of nonlinear optical signals, and this had also been the case for avalanching, until now.

Jan 13, 2021

New Research Could Enable Direct Data Transfer From Computers to Living Cells

Posted by in categories: biotech/medical, computing

“This is perhaps the hardest part of all DNA storage approaches. If you can get the cells to directly talk to a computer, and interface its DNA-based memory system with a silicon-based memory system, then there are lots of possibilities in the future.”

The work builds on a CRISPR-based cellular recorder Wang had previously designed for E. coli bacteria, which detects the presence of certain DNA sequences inside the cell and records this signal into the organism’s genome.

The system includes a DNA-based “sensing module” that produces elevated levels of a “trigger sequence” in response to specific biological signals. These sequences are incorporated into the recorder’s “DNA ticker tape” to document the signal.

Jan 13, 2021

Researchers create a highly sensitive biohybrid olfactory sensor

Posted by in categories: bioengineering, biotech/medical, chemistry, evolution

A keen sense of smell is a powerful ability shared by many organisms. However, it has proven difficult to replicate by artificial means. Researchers combined biological and engineered elements to create what is known as a biohybrid component. Their volatile organic compound sensor can effectively detect odors in gaseous form. They hope to refine the concept for use in medical diagnosis and the detection of hazardous materials.

Electronic devices such as cameras, microphones and pressure sensors enable machines to sense and quantify their environments optically, acoustically and physically. Our sense of smell however, despite being one of nature’s most primal senses, has proven very difficult to replicate artificially. Evolution has refined this sense over millions of years and researchers are working hard to catch up.

“Odors, airborne chemical signatures, can carry useful information about environments or samples under investigation. However, this information is not harnessed well due to a lack of sensors with sufficient sensitivity and selectivity,” said Professor Shoji Takeuchi from the Biohybrid Systems Laboratory at the University of Tokyo. “On the other hand, biological organisms use information extremely efficiently. So we decided to combine existing biological sensors directly with artificial systems to create highly sensitive volatile organic compound (VOC) sensors. We call these biohybrid sensors.”

Jan 13, 2021

Parabiosis: the Dilution Solution?

Posted by in categories: biotech/medical, life extension

Summary: Scientists have long marveled at the rejuvenating effects of heterochronic parabiosis. When you mix the blood of a young mouse and an old mouse by joining their circulatory systems, the older animal recovers some features of youth, while the young animal becomes functionally older. While many have assumed that these effects were driven by the infusion of pro-youth factors from the young parabiont into the older one, an alternative “Dilution Solution” hypothesis is possible: that the young blood is instead diluting pro-aging factors from the old animal’s blood, as well as allowing the young animal’s livers and kidneys to filter out metabolic toxins through the young animals’ livers and kidneys.


In heterochronic parabiosis, joining the circulatory systems of young and old mice causes the older animal to recover some features of youth. The effect has been widely assumed to be driven by pro-youth factors in younger blood, but an alternative hypothesis is possible: that the procedure is instead diluting pro-aging factors in the older partner.

Jan 13, 2021

Researchers identify promising model for studying human aging

Posted by in categories: biotech/medical, life extension, neuroscience

Aging research fans might like.

“In their work, Hamiliton’s team found that the Dunkin Hartley guinea pig was a good candidate for a muscle aging model due to the animal’s tendency to develop osteoarthritis (OA) at a young age.”


There are many components to aging, both mental and physical. When it comes to the infrastructure of the human body—the musculoskeletal system that includes muscles, bones, tendons and cartilage—age-associated decline is inevitable, and the rate of that decline increases the older we get. The loss of muscle function—and often muscle mass—is scientifically known as sarcopenia or dynapenia.

Continue reading “Researchers identify promising model for studying human aging” »

Jan 13, 2021

Artificial Flesh

Posted by in categories: biological, biotech/medical, ethics, food, futurism, health, innovation, science, sustainability

Review: Meat Planet (2019) by Benjamin Aldes Wurgaft

In the words of the book’s author, Benjamin Aldes Wurgaft, Meat Planet: Artificial Flesh and the Future of Food (2019) is “not an attempt at prediction but rather a study of cultured meat as a special case of speculation on the future of food, and as a lens through which to view the predictions we make about how technology changes the world.” While not serving as some crystal ball to tell us the future of food, Wurgaft’s book certainly does serve as a kind of lens.

Our very appetites are questioned quite a bit in the book. Wondering about the ever-changing history of food, the author asks, “Will it be an effort to reproduce the industrial meat forms we know, albeit on a novel, and more ethical and sustainable, foundation?” Questioning why hamburgers are automatically the default goal, he points out cultured meat advocates should carefully consider “the question of which human appetite for meat, in historical terms, they wish to satisfy.”

Wurgaft’s question of “which human appetite” – past, present, or future – is an excellent one. If we use his book as a lens to observe other emerging technologies, the question extends well beyond our choices of food. It could even have direct implications for such endeavours as radical life extension. Will we, if we extend our lifetimes, be satisfactory to future people? We already know the kind of clash that persists between different generations, and the blame we often place on previous generations for current social ills, without there also being a group of people who simply refuse to die. We should be wary of basing our future on the present – of attempting to preserve present tastes as somehow immutable and deserving immortality. This may be a problem such futurists as Ray Kurzweil, author of The Singularity is Near (2005) need to respond to.

If we are to justify the singularity at which we or our appetites are immortalized, we should remember technology changes “morality’s horizon”, as Wurgaft observes. If, for example, a new technology arises that can entirely eliminate suffering, our choice to allow suffering is an immoral one. If further technologies then emerge that can eliminate not just suffering but death, it will become immoral on that day to permit someone’s natural death – at least to the extent it is like the crime of manslaughter. I argued in my own book that it will be immoral to withhold novel biotechnologies from impoverished countries, if we know such direct action will increase their economic independence or improve their health. Put simply, our inaction in a situation can become an immoral deed if we have the necessary tools to stop suffering.

Continue reading “Artificial Flesh” »

Jan 13, 2021

Dr Halima Benbouza — Leading Biotech Development In Algeria For Health, Agriculture and Conservation

Posted by in categories: bioengineering, biotech/medical, education, food, genetics, government, health

Dr. Halima Benbouza is an Algerian scientist in the field of agronomic sciences and biological engineering.

She received her doctorate in 2004 from the University Agro BioTech Gembloux, Belgium studying Plant Breeding and Genetics and was offered a postdoctoral position to work on a collaborative project with the Agricultural Research Service, United States Department of Agriculture in Stoneville, Mississippi.

Continue reading “Dr Halima Benbouza — Leading Biotech Development In Algeria For Health, Agriculture and Conservation” »

Jan 13, 2021

Aubrey de Grey Longevity Q&A — The last 25 years, SENS, Longevity Escape Velocity, & More

Posted by in categories: bioengineering, biotech/medical, cryonics, life extension, mathematics, neuroscience

Annotated!


Aubrey David Nicholas Jasper de Grey is an English author and biomedical gerontologist. He is the Chief Science Officer of the SENS Research Foundation and VP of New Technology Discovery at AgeX Therapeutics.
Feel free to ask any related questions that you want Aubrey to try and answer!

Continue reading “Aubrey de Grey Longevity Q&A — The last 25 years, SENS, Longevity Escape Velocity, & More” »